Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Svendborg
Clinical trial register · Denmark

Clinical Trials in Svendborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Odense University Hospital12 University of Aarhus3 Novo Nordisk A/S3 AstraZeneca2 Janssen Research & Development, LLC2
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Svendborg

31 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease
NCT07835828Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF), Cardiovascular Diseases
Odense University Hospital
Not applicable
500
Svendborg
2026-10-01
Recruiting
AstraZeneca
Phase 3
600
Aarhus, Copenhagen, Gandrup, Herlev, Herning, Svendborg, Vejle, Viborg
2026-08-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Viborg, Gandrup, Esbjerg, Svendborg
2026-06-30
Recruiting
Early Cognitive Changes After Same-day Discharge Hip and Knee Arthroplasty
NCT07598552Postoperative Cognitive Dysfunction (POCD), Cognitive Change, Total Knee Arthroplasty, Unicompartmental Knee Arthroplasty
Odense University Hospital
Observational
48
Svendborg
2026-05-18
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Aabenraa, Frederiksberg, Herlev, Hjørring, Holbæk, Hvidovre, København Ø, Svendborg
2026-05-11
Recruiting
University of Aarhus
Observational
175
Aalborg, Aarhus, Glostrup Municipality, Horsens, Silkeborg, Svendborg, Vejle
2026-05-06
Not yet open
Odense University Hospital
Not applicable
100
Svendborg
2026-01
Recruiting
The AIDPRO-CRC Trial
NCT06645015Colo-rectal Cancer
Zealand University Hospital
Not applicable
1,200
Aalborg, Copenhagen NV, Herning, Hillerød, Hvidovre, Randers, Svendborg, Viborg
2025-10-24
Recruiting
Kresten Krarup Keller
Observational
149
Aarhus, Gødstrup, Horsens, Odense, Randers, Silkeborg, Svendborg
2025-08-21
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
165
Esbjerg, Odense C, Svendborg, Vejle
2025-02-26
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-02-21
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-01-09
Not yet open
More Steps Towards an Active Life After Stroke - ActForStroke
NCT06715566Stroke Not Otherwise Specified
University of Aarhus
Not applicable
50
Aalborg, Brønderslev, Copenhagen, Hammel, Jammerbugt, Skive, Svendborg, Thisted
2025-01-01
Recruiting
Odense University Hospital
Phase 4
375
Kolding, Svendborg
2024-10-07
Active, closed
AstraZeneca
Phase 3
310
Aalborg, Hvidovre, Svendborg, Vejle
2024-09-30
Recruiting
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NCT06614647Colorectal Cancer, Quality of Life, Survivorship
University of Aarhus
Not applicable
400
Herning, Randers, Aalborg, Odense, Svendborg, Aarhus, Copenhagen, Horsens
2024-09-15
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Herlev, Hillerød, Copenhagen NV, Hvidovre, Aarhus, Randers, Køge, Svendborg
2024-08-07
Active, closed
Odense University Hospital
Not applicable
1,332
Odense, Svendborg
2024-08-05
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Hellerup, Aalborg, Aarhus N, Gistrup, Hillerød, København Ø, Odense C, Svendborg
2024-06-25
Recruiting
The Cardio-Metabolic Clinic
NCT06203860Diabetes Mellitus, Type 2, Cardiovascular Diseases
Odense University Hospital
Not applicable
1,600
Svendborg
2024-01-01
Recruiting
Schema Therapy for Patients With Chronic Treatment Resistant Depression
NCT05833087Treatment Resistant Depression, Chronic Depression
Region of Southern Denmark
Not applicable
129
Ballerup Municipality, Copenhagen, Frederiksberg, Odense, Svendborg
2023-04-17
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Herlev, Aarhus N, Holbæk, Svendborg, Herning, Hillerød, Kolding, Slagelse
2023-03-01
Active, closed
ROBot Assisted Physical Training of Older Patients During acUte hospitaliSaTion
NCT05782855Functional Decline, ADL, Physical Inactivity, Acute Illness
Odense University Hospital
Not applicable
488
Svendborg
2023-01-05
Not yet open
Odense University Hospital
Observational
330
Svendborg
2022-03-01
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Herning, Aarhus N, Esbjerg, Glostrup Municipality, Herlev, Hjørring, Roskilde, Svendborg
2021-11-23
Not yet open
Odense University Hospital
Observational
330
Svendborg
2021-11-15
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Aarhus, Esbjerg, Gistrup, Hellerup, Herning, Odense, Roskilde, Svendborg
2021-08-14
Recruiting
Odense University Hospital
Observational
600
Svendborg
2020-05-01
Active, closed
University Hospital, Gentofte, Copenhagen
Not applicable
350
Copenhagen, Randers, Silkeborg, Aarhus, Farsø, Frederikshavn, Næstved, Svendborg
2017-08-17
Active, closed
Danish Cardiovascular Screening Trial II
NCT03946410Cardiac Disease, Vascular Diseases
Odense University Hospital
Not applicable
38,000
Odense, Silkeborg, Svendborg, Vejle
2017-08-01
Active, closed
Fat Around Heart Arteries as a Measure of Inflammation in Patients With Glycometabolic Disease
NCT07144670Obesity &Amp; Overweight, Obesity Type 2 Diabetes Mellitus, Type 2 Diabetes (T2DM), Prediabetes
Odense University Hospital
Observational
747
Svendborg
2016-03
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/svendborg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies with a site in Svendborg.

How many clinical trials are recruiting in Svendborg?

16 of the 31 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 4 have not yet opened recruitment, 10 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Svendborg), 31 studies
PhaseStudiesRecruitingShare
Not applicable12638.7%
Phase 39329%
Observational7422.6%
Phase 4226.5%
Phase 2113.2%

Most active sponsors

Lead sponsors with the most studies (Svendborg)
Lead sponsorStudiesRecruiting
Odense University Hospital125
Novo Nordisk A/S31
University of Aarhus32
AstraZeneca21
Janssen Research & Development, LLC21
Alimentiv Inc.11
Esbjerg Hospital - University Hospital of Southern Denmark11
Kresten Krarup Keller11
Merck Sharp & Dohme LLC11
Novartis Pharmaceuticals10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.